206 related articles for article (PubMed ID: 21417870)
21. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
[TBL] [Abstract][Full Text] [Related]
22. Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.
Post MJ; Lass-Floerl C; Gastl G; Nachbaur D
Transpl Infect Dis; 2007 Sep; 9(3):189-95. PubMed ID: 17511828
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Bielorai B; Toren A; Wolach B; Mandel M; Golan H; Neumann Y; Kaplinisky C; Weintraub M; Keller N; Amariglio N; Paswell J; Rechavi G
Bone Marrow Transplant; 2000 Nov; 26(9):1025-8. PubMed ID: 11100285
[TBL] [Abstract][Full Text] [Related]
24. Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients.
Hamza NS; Ghannoum MA; Lazarus HM
Bone Marrow Transplant; 2004 Sep; 34(5):377-89. PubMed ID: 15247928
[TBL] [Abstract][Full Text] [Related]
25. Pediatric invasive fungal infections: realities, challenges, concerns, myths and hopes.
Dinleyici EC
Expert Rev Anti Infect Ther; 2011 Mar; 9(3):273-4. PubMed ID: 21417863
[No Abstract] [Full Text] [Related]
26. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
27. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.
Gavalda J; Len O; San Juan R; Aguado JM; Fortun J; Lumbreras C; Moreno A; Munoz P; Blanes M; Ramos A; Rufi G; Gurgui M; Torre-Cisneros J; Montejo M; Cuenca-Estrella M; Rodriguez-Tudela JL; Pahissa A;
Clin Infect Dis; 2005 Jul; 41(1):52-9. PubMed ID: 15937763
[TBL] [Abstract][Full Text] [Related]
29. Factors associated with mortality in transplant patients with invasive aspergillosis.
Baddley JW; Andes DR; Marr KA; Kontoyiannis DP; Alexander BD; Kauffman CA; Oster RA; Anaissie EJ; Walsh TJ; Schuster MG; Wingard JR; Patterson TF; Ito JI; Williams OD; Chiller T; Pappas PG
Clin Infect Dis; 2010 Jun; 50(12):1559-67. PubMed ID: 20450350
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary aspergillosis in solid organ transplant patients: a report from Iran.
Marjani M; Tabarsi P; Najafizadeh K; Rashid Farokhi F; Sharifkashani B; Motahari S; Abbasi A; Masjedi MR; Mansouri D
Transplant Proc; 2008 Dec; 40(10):3663-7. PubMed ID: 19100461
[TBL] [Abstract][Full Text] [Related]
31. Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?
Leather HL; Wingard JR
Curr Opin Infect Dis; 2006 Aug; 19(4):371-9. PubMed ID: 16804386
[TBL] [Abstract][Full Text] [Related]
32. [The value of serum galactomannan detection for diagnosis of invasive aspergillosis in hematopoietic stem cell transplant recipients].
Ji Y; Liu DH; Xu LP; Liu KY; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):83-6. PubMed ID: 17650666
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
34. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
35. Aspergillus infections in the critically ill.
Dutkiewicz R; Hage CA
Proc Am Thorac Soc; 2010 May; 7(3):204-9. PubMed ID: 20463249
[TBL] [Abstract][Full Text] [Related]
36. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.
Zaoutis TE; Heydon K; Chu JH; Walsh TJ; Steinbach WJ
Pediatrics; 2006 Apr; 117(4):e711-6. PubMed ID: 16533892
[TBL] [Abstract][Full Text] [Related]
38. [Management of aspergillosis in immunocompromised patients. Recommendations of Lille University Hospital--4th version--November 2004].
Alfandari S; Leroy O; de Botton S; Yakoub-Agha I; Durand-Joly I; Leroy-Cotteau A; Beaucaire G;
Med Mal Infect; 2005 Mar; 35(3):121-34. PubMed ID: 15911182
[TBL] [Abstract][Full Text] [Related]
39. Antifungal prophylaxis in solid-organ transplant recipients: considerations for clinical trial design.
Singh N
Clin Infect Dis; 2004 Oct; 39 Suppl 4():S200-6. PubMed ID: 15546118
[TBL] [Abstract][Full Text] [Related]
40. Clinical risk factors for invasive aspergillosis.
Baddley JW
Med Mycol; 2011 Apr; 49 Suppl 1():S7-S12. PubMed ID: 20718606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
